Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...
What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never ...
The Food and Drug Administration has just approved a preventative HIV drug widely regarded as a breakthrough. On Wednesday afternoon, the FDA approved Gilead Sciences’ lenacapavir as a more convenient ...
Mother-to-child transmission often led to pretreatment drug resistance and acquired drug resistance in children living with HIV. The rate of transmission of HIV from a mother to her child without ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection ...
A newly approved medication to prevent HIV infection that can be injected twice a year is being hailed as a breakthrough in the fight against HIV/AIDS. “It is a wonder drug,” said Rama Rao Amara, an ...
Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...
LONDON (AP) — The European Medicines Agency has recommended authorizing a twice-yearly injectable drug aimed at preventing HIV, which scientists say could help end the virus’ transmission. In a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback